메뉴 건너뛰기
International Journal of Cancer
Volumn 135, Issue 1, 2014, Pages 250-251
Immortal time bias in retrospective analysis: Is there a survival benefit in patients with glioblastoma who received prolonged treatment of adjuvant valganciclovir?
Author keywords

[No Author keywords available]
Indexed keywords

ANTIVIRAL AGENTS; BRAIN NEOPLASMS; CYTOMEGALOVIRUS; FEMALE; GANCICLOVIR; GLIOBLASTOMA; HUMANS; MALE;
EID: 84899430653     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28664     Document Type: Editorial
Times cited : (15)
References (7)
  • 1
    • 84879247198 scopus 로고    scopus 로고
    • Effects of valganciclovir as an add-on therapy in patients with cytomegalovirus-positive glioblastoma: A randomized, double-blind, hypothesis-generating study
    • Stragliotto G, Rahbar A, Solberg NW, et al. Effects of valganciclovir as an add-on therapy in patients with cytomegalovirus-positive glioblastoma: A randomized, double-blind, hypothesis-generating study. Int J Cancer 2013; 133: 1204-13.
    • (2013) Int J Cancer , vol.133 , pp. 1204-1213
    • Stragliotto, G.1    Rahbar, A.2    Solberg, N.W.3
  • 2
    • 84883439743 scopus 로고    scopus 로고
    • Survival in patients with glioblastoma receiving valganciclovir
    • Soderberg-Naucler C, Rahbar A, Stragliotto G,. Survival in patients with glioblastoma receiving valganciclovir. N Engl J Med 2013; 369: 985-6.
    • (2013) N Engl J Med , vol.369 , pp. 985-986
    • Soderberg-Naucler, C.1    Rahbar, A.2    Stragliotto, G.3
  • 3
    • 77951579430 scopus 로고    scopus 로고
    • Problem of immortal time bias in cohort studies: Example using statins for preventing progression of diabetes
    • Levesque LE, Hanley JA, Kezouh A, et al. Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes. BMJ 2010; 340: b5087.
    • (2010) BMJ , vol.340
    • Levesque, L.E.1    Hanley, J.A.2    Kezouh, A.3
  • 4
    • 44049108508 scopus 로고    scopus 로고
    • The secret of immortal time bias in epidemiologic studies
    • Shariff SZ, Cuerden MS, Jain AK, et al. The secret of immortal time bias in epidemiologic studies. J Am Soc Nephrol 2008; 19: 841-3.
    • (2008) J Am Soc Nephrol , vol.19 , pp. 841-843
    • Shariff, S.Z.1    Cuerden, M.S.2    Jain, A.K.3
  • 5
    • 68949133055 scopus 로고    scopus 로고
    • Immortal person-time in studies of cancer outcomes
    • Lash TL, Cole SR,. Immortal person-time in studies of cancer outcomes. J Clin Oncol 2009; 27: e55-e56.
    • (2009) J Clin Oncol , vol.27
    • Lash, T.L.1    Cole, S.R.2
  • 6
    • 39349101029 scopus 로고    scopus 로고
    • Immortal time bias in pharmaco-epidemiology
    • Suissa S,. Immortal time bias in pharmaco-epidemiology. Am J Epidemiol 2008; 167: 492-9.
    • (2008) Am J Epidemiol , vol.167 , pp. 492-499
    • Suissa, S.1
  • 7
    • 4444283796 scopus 로고    scopus 로고
    • Time-dependent bias was common in survival analyses published in leading clinical journals
    • van Walraven C, Davis D, Forster AJ, et al. Time-dependent bias was common in survival analyses published in leading clinical journals. J Clin Epidemiol 2004; 57: 672-82.
    • (2004) J Clin Epidemiol , vol.57 , pp. 672-682
    • Van Walraven, C.1    Davis, D.2    Forster, A.J.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.